Worldwide Healthcare Trust - Strong performance since inception
Worldwide Healthcare Trust (WWH) will be celebrating its 30th birthday in 2025 and, despite more recent underperformance, the trust has served its shareholders well over the long term. Its NAV and share price total returns of +4,770% and +4,181% respectively, since launch in April 1995 to the end of September 2024, are considerably ahead of the benchmark’s +2,438% total return. Co-managers, Sven Borho and Trevor Polischuk, at global healthcare specialist OrbiMed, remain bullish on the industry outlook. They believe that the sector is poised for a catch-up in relative performance, having uncharacteristically lagged the performance of the broad US market in recent quarters. The managers point to favourable healthcare industry fundamentals, which include a high level of innovation, a supportive regulatory environment and robust levels of M&A activity. This is partly due to an upcoming patent cliff and senior executives at major pharma companies have been vocal about the need to replenish their product lines as their key drugs go off patent.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.